The Relationship Between the Residual Renal Function and Osteoporosis Treatment

Overview

The relationship between osteoporosis drugs and kidney damage is unclear. In this study, we plan to reveal relationship between osteoporosis drugs and kidney damage.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: December 2018

Detailed Description

Chronic kidney disease (CKD)- mineral and bone disorder (CKD-MBD) is one of the topic in osteoporosis treatment. As many osteoporotic patients are older, many patients are under the deterioration of the renal function. In addition, several drugs might have the potential for kidney damage. But the relationship between osteoporosis drugs and kidney damage is unclear.

The main objective of this study is to reveal relationship between osteoporosis drugs and kidney damage.

Interventions

  • Drug: Bis, SERM Teriparatide, Denosumab
    • Osteoporotic drugs are assigned according to the disease severity, gender, age and so on.

Arms, Groups and Cohorts

  • Bisphosphonate
  • Selective estrogen receptor modulator
  • Teriparatide
  • Senosumab

Clinical Trial Outcome Measures

Primary Measures

  • Longitudinal renal function changes by osteoporotic treatment
    • Time Frame: Up to 120 months

Participating in This Clinical Trial

Inclusion Criteria

  • Osteoporosis patients

Exclusion Criteria

  • eGFR < 15

Gender Eligibility: All

Minimum Age: 45 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Toshihiko Kono
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Toshihiko Kono, Head of Hospital – Tomidahama Hospital
  • Overall Official(s)
    • Rui Niimi, MD, Principal Investigator, Tomidahama Hospital
  • Overall Contact(s)
    • Rui Niimi, MD, (81)-59-365-0023, furikakefuri@hotmail.co.jp

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.